AstraZeneca Gonorrhoea Drug Fast-Tracked By FDA, Updates On Pipeline
LONDON (Alliance News) - AstraZeneca PLC Tuesday announced that its investigational drug AZD0914 for the treatment of uncomplicated gonorrhoea had been granted 'fast track' status by the US Food and Drug Administration, while also providing details of the development of its oncology pipeline. Read More